Georg Mellitzer

Dr. Georg Mellitzer

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2011 in Journal of Cell Biology
Verified
Journal Article
Open access
FGFrançois Gerbe
François Gerbe
JEJohan H. van Es
Johan H. van Es
LMLeila Makrini
Leila Makrini
BBBénédicte Brulin
Bénédicte Brulin
GMGeorg Mellitzer
Georg Mellitzer
PJPhilippe Jay
Philippe Jay
The unique morphology of tuft cells was first revealed by electron microscopy analyses in several endoderm-derived epithelia. Here, we explore the relationship of these cells with the other cell types of the intestinal epithelium and describe the first marker signature allowing their unambiguous identification. We demonstrate that although mature tuft cells express DCLK1, a putative marker of quiescent stem cells, they are post-mitotic, short lived, derive from Lgr5-expressing epithelial stem cells, and are found in mouse and human tumors. We show that whereas the ATOH1/MATH1 transcription factor is essential for their differentiation, Neurog3, SOX9, GFI1, and SPDEF are dispensable, which distinguishes these cells from enteroendocrine, Paneth, and goblet cells, and raises from three to four the number of secretory cell types in the intestinal epithelium. Moreover, we show that tuft cells are the main source of endogenous intestinal opioids and are the only epithelial cells that express cyclooxygenase enzymes, suggesting important roles for these cells in the intestinal epithelium physiopathology.

1 July 1999 in Nature
Verified
Journal Article
Closed access
GMGeorg Mellitzer
Georg Mellitzer
QXQiling Xu
Qiling Xu
DWDavid G. Wilkinson
David G. Wilkinson

1 May 1999 in Nature
Verified
Journal Article
Closed access
PDF file
QXQiling Xu
Qiling Xu
GMGeorg Mellitzer
Georg Mellitzer
VRVicky Robinson
Vicky Robinson
DWDavid G. Wilkinson
David G. Wilkinson

2 March 2006 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
GMGeorg Mellitzer
Georg Mellitzer
SBStefan Bonné
Stefan Bonné
RLReini Luco
Reini Luco
MCMark Van De Casteele
Mark Van De Casteele
NLNathalie Lenne‐Samuel
Nathalie Lenne‐Samuel
HHHarry Heimberg
Harry Heimberg
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 October 2005 in Developmental Biology
Verified
Journal Article
Closed access
RHR. Scott Heller
R. Scott Heller
MJMarjorie Jenny
Marjorie Jenny
PCPatrick Collombat
Patrick Collombat
AMAhmed Mansouri
Ahmed Mansouri
Catherine TOMASETTOCatherine TOMASETTO
Catherine TOMASETTO
PSPalle Serup
Palle Serup

15 January 2010 in Development
Verified
Journal Article
Closed access
PDF file
JSJosselin Soyer
Josselin Soyer
LFLydie Flasse
Lydie Flasse
WRWolfgang Raffelsberger
Wolfgang Raffelsberger
ABAnthony Beucher
Anthony Beucher
COChristophe Orvain
Christophe Orvain
GGGérard Gradwohl
Gérard Gradwohl
The transcription factor neurogenin 3 (Neurog3 or Ngn3) controls islet cell fate specification in multipotent pancreatic progenitor cells in the mouse embryo. However, our knowledge of the genetic programs implemented by Ngn3, which control generic and islet subtype-specific properties, is still fragmentary. Gene expression profiling in isolated Ngn3-positive progenitor cells resulted in the identification of the uncharacterized winged helix transcription factor Rfx6. Rfx6 is initially expressed broadly in the gut endoderm, notably in Pdx1-positive cells in the developing pancreatic buds, and then becomes progressively restricted to the endocrine lineage, suggesting a dual function in both endoderm development and islet cell differentiation. Rfx6 is found in postmitotic islet progenitor cells in the embryo and is maintained in all developing and adult islet cell types. Rfx6 is dependent on Ngn3 and acts upstream of or in parallel with NeuroD, Pax4 and Arx transcription factors during islet cell differentiation. In zebrafish, the Rfx6 ortholog is similarly found in progenitors and hormone expressing cells of the islet lineage. Loss-of-function studies in zebrafish revealed that rfx6 is required for the differentiation of glucagon-, ghrelin- and somatostatin-expressing cells, which, in the absence of rfx6, are blocked at the progenitor stage. By contrast, beta cells, whose number is only slightly reduced, were no longer clustered in a compact islet. These data unveil Rfx6 as a novel regulator of islet cell development.